Los Angeles Capital Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$153K Sell
936
-81,449
-99% -$12.5M ﹤0.01% 1213
2025
Q4
$16M Sell
82,385
-45,118
-35% -$8.23M 0.05% 193
2025
Q3
$18.4M Sell
127,503
-203,297
-61% -$24.9M 0.06% 195
2025
Q2
$33.3M Buy
330,800
+318,716
+2,638% +$24.4M 0.12% 134
2025
Q1
$922K Buy
12,084
+2,879
+31% +$220K ﹤0.01% 590
2024
Q4
$636K Sell
9,205
-974
-10% -$70.1K ﹤0.01% 749
2024
Q3
$743K Buy
10,179
+6,335
+165% +$468K ﹤0.01% 744
2024
Q2
$258K Buy
+3,844
New +$149K ﹤0.01% 1065
2021
Q2
Sell
-20,256
Closed -$690K 1607
2021
Q1
$690K Sell
20,256
-13,711
-40% -$524K ﹤0.01% 1075
2020
Q4
$1.13M Sell
33,967
-347
-1% -$12.7K ﹤0.01% 883
2020
Q3
$1.1M Buy
34,314
+1,830
+6% +$52.6K 0.01% 786
2020
Q2
$895K Sell
32,484
-8,530
-21% -$202K ﹤0.01% 884
2020
Q1
$657K Buy
41,014
+15,831
+63% +$375K ﹤0.01% 825
2019
Q4
$601K Buy
25,183
+3,645
+17% +$74.1K ﹤0.01% 974
2019
Q3
$380K Buy
21,538
+1,040
+5% +$20.1K ﹤0.01% 1072
2019
Q2
$525K Hold
20,498
﹤0.01% 1025
2019
Q1
$596K Buy
20,498
+3,690
+22% +$95.6K ﹤0.01% 1030
2018
Q4
$221K Sell
16,808
-47,065
-74% -$751K ﹤0.01% 1184
2018
Q3
$1.29M Sell
63,873
-18,807
-23% -$425K 0.01% 784
2018
Q2
$1.96M Buy
82,680
+8,400
+11% +$216K 0.01% 699
2018
Q1
$1.67M Buy
+74,280
New +$1.95M 0.01% 684
2016
Q3
Sell
-33,150
Closed -$327K 1247
2016
Q2
$327K Buy
+33,150
New +$387K ﹤0.01% 1024

Other funds holding INSM

Los Angeles Capital Management's INSM Position: Q1 2026 in Review

Los Angeles Capital Management reduced its Insmed (INSM) stake by 99% in Q1 2026, selling an estimated $12.5M and leaving 936 shares worth $153K. The position accounts for ﹤0.01% of the portfolio, ranked #1213.

Los Angeles Capital Management first reported a position in INSM in Q2 2016 and has held it in 22 quarters since. The position peaked at $33.3M in Q2 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Los Angeles Capital Management held 936 shares of Insmed worth $153K as of Q1 2026.
  • Los Angeles Capital Management sold 81,449 Insmed shares in Q1 2026, an estimated $12.5M.
  • Insmed made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #1213 holding.
  • Los Angeles Capital Management first reported a position in Insmed in Q2 2016 and has held it in 22 quarters since.
  • Los Angeles Capital Management's Insmed position peaked at $33.3M in Q2 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.